Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. USA
  4. disease agents
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • District Of Columbia
  • Florida
  • Georgia (Us)
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
Brands

  • asc
  • hygieia
  • medchemexpress

Disease Agents Equipment Supplied In Usa

6 equipment items found
In UsaAvailable In UsaNear Usa

Hygieia - Autogenous Vaccines

Hygieia - Autogenous Vaccines

Manufactured by:Hygieia Biological Laboratories   based inWoodland, CALIFORNIA (USA)
Preventative health including vaccination is a key focus of good animal management. Hygieia offers inactivated autogenous bacterins and vaccines which are custom manufactured from disease agents specifically found at an individual ranch, zoo, or other animal facility. This allows the producer or owner to tailor a vaccine formulation to target only problem ...
CONTACT SUPPLIER

ASC - Gene and Cell-Based Therapies Technology

ASC - Gene and Cell-Based Therapies Technology

Manufactured by:ASC Therapeutics   based inMilpitas, CALIFORNIA (USA)
We are developing gene and cell-based therapies. Gene therapy is addition, alteration or removal of genes within cells and biological tissues to treat diseases. A correcting genetic agent can be delivered directly to the blood stream in vivo, or to the affected tissue in situ, or the targeted cells can be modified ex vivo and injected back to the patients. ...
CONTACT SUPPLIER

Smallpox Therapeutic

Smallpox Therapeutic

Manufactured by:BioFactura, Inc.   based inFrederick, MARYLAND (USA)
With a mortality rate of over 30%, smallpox is one of the most dangerous biological threats. It is person-to-person airborne communicable, highly contagious and exhibits a long pre-symptomatic phase (12-14 days) allowing undetectable spread worldwide. While smallpox was declared eradicated in 1980 by the World Health Organization after an extensive vaccination campaign, the threat of bioterrorism ...
CONTACT SUPPLIER

Model STARS - Investigational Therapeutic Device Product

Model STARS - Investigational Therapeutic Device Product

Manufactured by:Qualigen Therapeutics, Inc.   based inCarlsbad, CALIFORNIA (USA)
These same technologies are now the basis for the Company’s expansion into therapeutic applications for the treatment of cancer and infectious disease. Qualigen’s Selective Target Antigen Removal System (STARS), is an investigational therapeutic device product currently under development and evaluation that will utilize core expertise in advanced reagents and coatings ...
CONTACT SUPPLIER

Model FT500 - Oncology Therapeutic Cell

Model FT500 - Oncology Therapeutic Cell

Manufactured by:Fate Therapeutics, Inc.   based inSan Diego, CALIFORNIA (USA)
Despite the clinical benefit conferred by approved checkpoint inhibitor therapy against a variety of tumor types, these therapies are not curative and, in most cases, patients either fail to respond or their disease progresses on these agents. Resistance to checkpoint inhibitor therapy has been linked to impaired immune cell infiltration into the tumor, impaired ...
CONTACT SUPPLIER

MedChemExpress - Model Lucatumumab - 903512-50-5

MedChemExpress - Model Lucatumumab - 903512-50-5

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT